Sotyktu (deucravacitinib)

pCPA File Number: 22432
Negotiation Status:
Concluded with an LOI
Indication(s):
Psoriasis, moderate to severe plaque
Sponsor/Manufacturer:
Bristol Myers Squibb Canada Inc.
CDA-AMC Project Number:
SR0756-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: